Basis Plan For Postmarketing Survelillances, Etc. Of New Ethical Drugs For Torisel

Trial Profile

Basis Plan For Postmarketing Survelillances, Etc. Of New Ethical Drugs For Torisel

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 06 Apr 2017

At a glance

  • Drugs Temsirolimus (Primary)
  • Indications Renal cell carcinoma
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 03 Apr 2017 Planned End Date changed from 1 Jun 2015 to 1 Jan 2018.
    • 03 Apr 2017 Planned primary completion date changed from 1 Jun 2015 to 1 Jan 2018.
    • 03 Apr 2017 Status changed from completed to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top